ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL

Objective: The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children. Methodology: Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yunus Murat Akcabelen, Volkan Köse, Dilek Gürlek Gökçebay, Turan Bayhan, Namık Yaşar Özbek, Neşe Yaralı
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/69644907b6294b168925d998716370b3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:69644907b6294b168925d998716370b3
record_format	dspace
spelling	oai:doaj.org-article:69644907b6294b168925d998716370b32021-11-10T04:38:14ZETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL2531-137910.1016/j.htct.2021.10.1068https://doaj.org/article/69644907b6294b168925d998716370b32021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2531137921012153https://doaj.org/toc/2531-1379Objective: The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children. Methodology: Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or examined at 6–12-month intervals. Results: A total of 328 patients with a mean age of 6.9 were included.Catheter-related thrombosis was present in 52.7%.There were 14% arterial thrombosis and 59% venous thrombosis.Intracardiac thrombosis 16.2%, pulmonar thrombosis 2.4%, serebral thromboembolism %20 were detected.In the treatment, subcutaneous ondansetron (78.6%) was used mostly, but intravenous ondansetron was given in 6 patients and TPA was given 20 patients.In a mean follow-up of 15.8 months, 5 (1.5%) patients died due to thrombosis. Conclusion: Determining the etiological factors of patients with recurrence thrombosis is important for the duration of treatment in the follow-up.Yunus Murat AkcabelenVolkan KöseDilek Gürlek GökçebayTuran BayhanNamık Yaşar ÖzbekNeşe YaralıElsevierarticleDiseases of the blood and blood-forming organsRC633-647.5ENHematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S54- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the blood and blood-forming organs RC633-647.5
spellingShingle	Diseases of the blood and blood-forming organs RC633-647.5 Yunus Murat Akcabelen Volkan Köse Dilek Gürlek Gökçebay Turan Bayhan Namık Yaşar Özbek Neşe Yaralı ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
description	Objective: The aim of the study; To determine the frequency, etiological factors, treatment, long-term follow-up and recurrence rates of thrombosis in children. Methodology: Children with thrombosis in Ankara City Hospital between December 2018 and August 2021 were included. Patients were called or examined at 6–12-month intervals. Results: A total of 328 patients with a mean age of 6.9 were included.Catheter-related thrombosis was present in 52.7%.There were 14% arterial thrombosis and 59% venous thrombosis.Intracardiac thrombosis 16.2%, pulmonar thrombosis 2.4%, serebral thromboembolism %20 were detected.In the treatment, subcutaneous ondansetron (78.6%) was used mostly, but intravenous ondansetron was given in 6 patients and TPA was given 20 patients.In a mean follow-up of 15.8 months, 5 (1.5%) patients died due to thrombosis. Conclusion: Determining the etiological factors of patients with recurrence thrombosis is important for the duration of treatment in the follow-up.
format	article
author	Yunus Murat Akcabelen Volkan Köse Dilek Gürlek Gökçebay Turan Bayhan Namık Yaşar Özbek Neşe Yaralı
author_facet	Yunus Murat Akcabelen Volkan Köse Dilek Gürlek Gökçebay Turan Bayhan Namık Yaşar Özbek Neşe Yaralı
author_sort	Yunus Murat Akcabelen
title	ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
title_short	ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
title_full	ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
title_fullStr	ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
title_full_unstemmed	ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
title_sort	etiology, treatment and follow-up of thrombosis in children, one center prospective trial
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/69644907b6294b168925d998716370b3
work_keys_str_mv	AT yunusmuratakcabelen etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT volkankose etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT dilekgurlekgokcebay etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT turanbayhan etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT namıkyasarozbek etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial AT neseyaralı etiologytreatmentandfollowupofthrombosisinchildrenonecenterprospectivetrial
_version_	1718440564918059008

ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL

Ejemplares similares